文献速递生殖医学

整倍体冻融囊胚移植周期结局相关的临床与实验室参数

Clinical and laboratory parameters associated with cycle outcomes in patients undergoing euploid frozen blastocyst transfer.
PubMed 文献 · Reprod Biomed Online · 2023-03-08

回顾性观察研究纳入2016年11月至2020年12月的1660个整倍体冻融胚胎移植周期、2439枚整倍体囊胚,评估临床与实验室参数对临床妊娠率、生化流产率、临床流产率和活产率的影响。每移植周期临床妊娠率63.4%、活产率51.6%;双胚胎移植临床妊娠率和活产率更高但流产率也更高;自然周期方案活产率更高,BMI正常组临床流产率更低、活产率更高。

要点

  • 每移植周期临床妊娠率63.4%、活产率51.6%。
  • 双胚胎移植临床妊娠率71.6% vs 57.7%、活产率55.2% vs 49.1%,但流产率28.8% vs 22.8%。
  • 自然周期方案活产率57.6%、48.8%、45.0%,高于激素替代方案和刺激周期。

核心结论

  • 活检日影响临床妊娠率,BMI和内膜准备方案与整倍体冻融胚胎移植的活产率相关。
  • 双胚胎移植应被劝阻,因其增加流产风险。
  • 高BMI女性即使移植整倍体囊胚,也应知晓流产风险更高和活产率更低。

研究设计与样本

  • 回顾性观察研究,纳入2016年11月至2020年12月的1660个整倍体冻融胚胎移植周期,含2439枚整倍体囊胚。
  • 评估临床与实验室参数对临床妊娠率、生化流产率、临床流产率和活产率的影响。

主要发现

  • 每移植周期临床妊娠率63.4%,活产率51.6%。
  • 双胚胎移植组临床妊娠率71.6% vs 57.7%(P < 0.001),活产率55.2% vs 49.1%(P = 0.016),流产率28.8% vs 22.8%(P = 0.02)。
  • 按BMI分类,临床妊娠率无差异,正常BMI组临床流产率更低(P < 0.001)、活产率更高(P = 0.031)。
  • 自然周期方案临床流产率更低(P < 0.001)、流产率更低(P < 0.001),活产率更高(57.6%、48.8%、45.0%,P = 0.001),优于激素替代方案和刺激周期。
  • 滋养层活检日影响临床妊娠率(P < 0.001)和活产率(P < 0.001),生化流产率、临床流产率和流产率无差异。

临床怎么用

  • 作者认为双胚胎移植应被劝阻,因其增加流产风险。
  • 作者认为高BMI女性即使移植整倍体囊胚,也应知晓流产风险更高和活产率更低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Which factors impact on clinical pregnancy rate (CPR) and live birth rates (LBR) in euploid frozen embryo transfer (eFET) cycles? DESIGN: Retrospective observational study including 1660 eFET cycles with 2439 euploid blastocysts, from November 2016 to December 2020. The impact of clinical and laboratory parameters on CPR, biochemical miscarriage rate (BMR), clinical miscarriage rate (CMR) and LBR was evaluated. RESULTS: CPR per transfer was 63.4%, LBR per transfer 51.6%. CPR and LBR were significantly higher when double embryo transfer (DET) was performed (71.6% versus 57.7%, P < 0.001; 55.2% versus 49.1%, P = 0.016, respectively). However, pregnancy loss was significantly higher in the DET group (28.8% versus 22.8%, P = 0.02). When patients were classified by body mass index (BMI), no differences were observed for CPR, but CMR was lower (P < 0.001) and LBR higher (p = 0.031) for the normal BMI group. The natural cycle protocol revealed lower CMR (P < 0.001) and lower pregnancy loss (P < 0.001); subsequently, higher LBR (57.6%, 48.8%, 45.0%, P = 0.001) compared with hormonal replacement protocol and stimulated cycle. Day of trophectoderm biopsy affected CPR (P < 0.001) and LBR (P < 0.001), yet no differences were observed for BMR, CMR or pregnancy loss. The multivariate analysis showed that day 6/7 embryos had lower probabilities for pregnancy; overweight and obesity had a negative impact on LBR, and natural cycle improved LBR (adjusted odds ratio 1.445, 95% confidence interval 0.519-0.806). CONCLUSIONS: Day of biopsy affected CPR, while BMI and endometrial preparation protocol were associated with LBR in eFET. DET should be discouraged as it will increase the risk of pregnancy loss. Women with higher BMI should be aware of the higher risk of pregnancy loss and lower LBR even though a euploid blastocyst is transferred.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Melado Vidales L, Lawrenz B, Vitorino RL, et al. Clinical and laboratory parameters associated with cycle outcomes in patients undergoing euploid frozen blastocyst transfer. Reprod Biomed Online. 2023. PMID: 37062636. doi:10.1016/j.rbmo.2023.02.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。